This is a prospective, multicenter, longitudinal observational cohort study aimed at understanding the progression of Duchenne Muscular Dystrophy (DMD). The primary objective is to identify and integrate key biomarkers from multiple sources-including motor function assessments, body composition (muscle and fat distribution), clinical laboratory tests, and cardiopulmonary imaging-to delineate comprehensive disease trajectories. By analyzing how these factors change over time in a large cohort, the study seeks to develop a robust model that can identify patterns of disease progression. The ultimate goal is to generate evidence that may aid in forecasting individual patient outcomes and inform the future development of personalized rehabilitation and therapeutic strategies.
Male participants with genetically confirmed diagnosis of Duchenne Muscular Dystrophy (DMD) or Becker Muscular Dystrophy (BMD)
Age range: 1 to 18 years old (adjust to your actual age limit)
Ability to complete study assessments and follow-up visits
Participants or legal guardians provide written informed consent
Participants with other neuromuscular disorders that may confound natural history data
Participation in another interventional clinical trial that could affect disease progression
Severe comorbidities that prevent completion of study assessments
Inability to provide informed consent or comply with study procedures